University of Edinburgh — Biomedical Watch V2

Traitements6programmes

Essais3liés

Publications0liées

SourceDBlocale

Traitements

6

Molécule	Indication / population	Phase	Objectif	Pays	Résultat
Computed tomography coronary angiography (CTCA)Cardiovascular disease (for example, heart attack, stroke, heart failure) is the commonest complication of kidney failure. Kidney transplantation reduces cardiovascular risk but cardiovascular disease remains the commonest cause of death in patients following transplantation. Current strategies to assess patient's cardiovascular risk prior to kidney transplantation do not identify those at highest risk and do not improve outcomes. This study will use a heart scan known as computed tomography coronary angiography (CTCA) to see whether this scan can identify patients at highest risk of future cardiovascular disease prior to transplantation. Studies have shown it is able to do this in patients with normal kidney function. The aim of this study is to develop CTCA as an effective tool to risk stratify patients prior to kidney transplantation.	Maladie coronarienne, Maladie rénale chronique	À vérifier	À vérifier	United Kingdom	À vérifier
Digital App for Speech & Health MonitoringMany people living with neurodegenerative conditions like dementia, motor neuron disease (MND), multiple sclerosis (MS), and Parkinson's disease (PD), suffer from speech problems. Using common digital technologies such as smartphone apps, the investigators can record and analyse speech in detail to provide new information for people living with these conditions, researchers, and healthcare professionals. This study will investigate the use of these digital speech recordings to help diagnose and monitor these conditions. To take part, participants will have either a diagnosis of dementia, motor neuron disease, Parkinson's disease or Multiple Sclerosis, OR they will have no diagnosis of a neurological condition. Researchers will compare people with a diagnosis of a Neurological condition to those without.	Parkinson, SEP	À vérifier	À vérifier	United Kingdom	À vérifier
DISCOVER — Reducing Risk of Stroke and DementIa In patientS With COVert cERebrovascular DiseaseThe purpose of the DISCOVER study is to pilot acceptable approaches to people with covert cerebrovascular disease (CCD) and their follow-up. This is the first step in designing efficient randomised trials of treatments to reduce the risk of stroke or dementia in people with CCD.	Myopathies	À vérifier	À vérifier		À vérifier
Digital App for Speech & Health MonitoringMany people living with neurodegenerative conditions like dementia, motor neuron disease (MND), multiple sclerosis (MS), and Parkinson's disease (PD), suffer from speech problems. Using common digital technologies such as smartphone apps, the investigators can record and analyse speech in detail to provide new information for people living with these conditions, researchers, and healthcare professionals. This study will investigate the use of these digital speech recordings to help diagnose and monitor these conditions. To take part, participants will have either a diagnosis of dementia, motor neuron disease, Parkinson's disease or Multiple Sclerosis, OR they will have no diagnosis of a neurological condition. Researchers will compare people with a diagnosis of a Neurological condition to those without.	SEP	À vérifier	À vérifier	United Kingdom	À vérifier
DISCOVER — Reducing Risk of Stroke and DementIa In patientS With COVert cERebrovascular DiseaseThe purpose of the DISCOVER study is to pilot acceptable approaches to people with covert cerebrovascular disease (CCD) and their follow-up. This is the first step in designing efficient randomised trials of treatments to reduce the risk of stroke or dementia in people with CCD.	Myopathies	À vérifier	À vérifier		À vérifier
Computed tomography coronary angiography (CTCA)Cardiovascular disease (for example, heart attack, stroke, heart failure) is the commonest complication of kidney failure. Kidney transplantation reduces cardiovascular risk but cardiovascular disease remains the commonest cause of death in patients following transplantation. Current strategies to assess patient's cardiovascular risk prior to kidney transplantation do not identify those at highest risk and do not improve outcomes. This study will use a heart scan known as computed tomography coronary angiography (CTCA) to see whether this scan can identify patients at highest risk of future cardiovascular disease prior to transplantation. Studies have shown it is able to do this in patients with normal kidney function. The aim of this study is to develop CTCA as an effective tool to risk stratify patients prior to kidney transplantation.	Maladie coronarienne	À vérifier	À vérifier	United Kingdom	À vérifier

Essais cliniques

3

Molécule	Indication / population	Phase	NCT	Titre	Statut
Computed tomography coronary angiography (CTCA)	Maladie coronarienne	À vérifier	NCT06234410	CRAFT-CTCA — Cardiovascular Risk Assessment For Kidney Transplantation - Utility of Computed Tomography Coronary Angiography in the Assessment of Patients Awaiting Kidney Transplantation	RECRUITING
DISCOVER — Reducing Risk of Stroke and DementIa In patientS With COVert cERebrovascular Disease	Myopathies	À vérifier	NCT06878430	DISCOVER — Reducing Risk of Stroke and DementIa In patientS With COVert cERebrovascular Disease	NOT_YET_RECRUITING
Digital App for Speech & Health Monitoring	SEP	À vérifier	NCT06450418	Digital App for Speech & Health Monitoring	RECRUITING

Publications

0

Molécule	Indication / population	Titre	Journal	Date
Aucune publication.